Learning Objectives
After completing this activity, the participant should be better able to:
Have increased knowledge regarding the
- Latest clinical practice guidelines for the care of patients with CV conditions
- Clinical trial data for new and emerging therapies across the spectrum of CVD
Have greater competence related to
- Tailoring treatment for patients with CVD and/or comorbidities
Demonstrate greater confidence in their ability to
- Communicate effectively and work as part of the interprofessional team to optimize the care of patients with/at risk for CVD
Joint Accreditation Statement
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this live activity for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Awarded 13.00 contact hour(s) of nursing continuing professional development for RNs and APNs; final contact hours in the area of pharmacology will be posted on the conference platform.
This activity was planned by and for the healthcare team, and learners will receive 13.00 Interprofessional Continuing Education (IPCE) credit for learning and change
